@BrighamResearch , @MGH_RI are the top 2 hospitals world-wide in research impact according to Nature. What a privilege to support and be a part of research @MassGenBrigham. nature.com/nature-index/n…
Stephen Wiviott
@swiviott
@BrighamWomens Cardiologist, @TIMIStudyGroup, @MassGenBrigham HeathCare, @HarvardMed, Father, Husband (not necessarily in that order).
600 Following 961 Followers 359 Posts
Latest posts 5
Another great podcast - this time with amazing colleague @DrM_ODonoghue. Always a lot to learn from her. This time about Lp(a) - a very hot area in prevention - even the 2 acceptable ways to say “Lp(a)!”
TIMI Senior Investigator @DrM_ODonoghue joins @marstonMD and @ddbergMD on the TIMI Talks Podcast to discuss Lp(a) therapies and the Ocean(a) trials. Listen now on all major podcast platforms!View quoted post on X
podcasts.apple.com/us/podcast/tim…
open.spotify.com/show/38F4RGeb3…
podcasts.google.com/search/TIMI%20…
Our science only works as a team effort. These impactful papers are a credit to the whole @TIMIStudyGroup - faculty, fellows, operations, statistics and so many more.
TIMI Senior Investigators Drs. Eugene Braunwald, Marc Sabatine & Stephen Wiviott have been named on the annual Highly Cited Researchers 2023 list by @Clarivate @swiviottView quoted post on X
clarivate.com/highly-cited-r…
Proud to see @CarolineFox5 and the team from @FlagshipPioneer launch this innovative company leveraging somatic genetics for target discovery. quotient-tx.com endpts.com/flagship-launc…
Major (67-73%) reduction in bleeding with #abelacimab compared to rivaroxiban with this novel Factor XI inhibitor, including near elimination of GI bleeding. #AHA23
AZALEA-TIMI 71 presented by Dr. Christian Ruff as #AHA23 Late Breaking Clinical Trial: The novel FXI inhibitor #abelacimab reduced bleeding by >=2/3 compared with rivaroxaban in AF patients. @rgiugliano @swiviott @sidpatelView quoted post on X